Hillsdale Investment Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25,700	Closed	-$789K	–	570
2022 Q3	$789K	Buy	+25,700	New	+$789K	0.07%	195
2021 Q3	–	Sell	-17,200	Closed	-$1.35M	–	576
2021 Q2	$1.35M	Sell	17,200 -1,000	-5%	-$78.4K	0.11%	177
2021 Q1	$1.04M	Buy	+18,200	New	+$1.04M	0.09%	246